- Business
- ARS Focused Opportunity Strategy ETF (AFOS) is an actively managed exchange-traded fund that seeks long-term capital appreciation by investing primarily in equity securities of undervalued companies across small-, mid-, and large-market capitalization ranges, characterized as growth and/or value orientations; the fund prioritizes industries benefiting from strong secular trends while avoiding those with secular headwinds, employing a high-conviction portfolio of approximately 30-31 holdings without benchmark constraints on capitalization size, stock weightings, or sector allocations. Top holdings typically include leading firms such as First American Government Obligations Fund, Western Digital, Alphabet Inc., NVIDIA Corporation, Newmont Corporation, Kratos Defense & Security Solutions, Lam Research Corp, Ascendis Pharma A/S, and CRH PLC, with sector weights diverging from indices like the S&P 500, emphasizing information technology, industrials, materials, and health care. The ETF offers investors a cost-effective alternative to mutual funds with an expense ratio of 0.45%, aiming to build purchasing power by outpacing inflation through companies poised for global capital flows and providing a complement to passive strategies with differentiated exposure.
Launched on June 25, 2025, and listed on Nasdaq with CUSIP 02072Q531, AFOS is advised by Empowered Funds, LLC (doing business as ETF Architect), headquartered in Newtown Square, Pennsylvania (previously Havertown, PA), with ARS Investment Partners, LLC serving as sub-adviser; ARS, founded in 1971 as A.R. Schmeidler & Co., Inc. and based at 529 Fifth Avenue, Suite 500, New York, NY, manages the portfolio with recent addition of Partner Andrew Schmeidler as portfolio manager. The fund's assets under management stand at approximately $183-192 million, with a weighted average market cap of $820 billion, low turnover, and geographic focus predominantly on North America (over 99%, primarily United States at 91%), with minor exposures to Europe and other regions.
Recent developments include the fund's inception via tax-deferred in-kind contributions under Section 351 of the Internal Revenue Code, an address update for the adviser to 3803 West Chester Pike, Suite 150, Newtown Square, PA 19073, and Andrew Schmeidler's appointment as portfolio manager effective post-launch; as sub-adviser, ARS Investment Partners has integrated AFOS into its strategies, with portfolio adjustments reflecting new positions in holdings like BWX Technologies, Regeneron Pharmaceuticals, and Blackstone amid ongoing active management.